Literature DB >> 22662869

Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Wei Cao1, Jie Xu, Zhan Mei Zhou, Guo Bao Wang, Fan Fan Hou, Jing Nie.   

Abstract

AIMS: Activation of intrarenal renin-angiotensin system (RAS) has a detrimental effect on the progression of chronic kidney diseases (CKDs), although the regulation of intrarenal RAS remains unclear. The aim of the present study was to evaluate the role of advanced oxidation protein products (AOPPs) in intrarenal RAS activation.
RESULTS: AOPPs upregulated the expression of almost all components of RAS and increased activity of angiotensin-converting enzyme in cultured proximal tubular epithelial cells. The triggering effect of AOPP-albumin was 100-times stronger than that of unmodified albumin. The effect of AOPP-albumin was mainly mediated by a CD36-dependent, redox-sensitive signaling involving activation of protein kinase Cα, NADPH oxidase, and nuclear factor-κB/activation protein-1. Chronic AOPP-albumin loading in unilateral nephrectomy rats resulted in deposition of AOPPs in renal tubular cells accompanied with local RAS activation and functional perturbations such as increase in urinary albumin excretion. Accumulation of AOPPs was also detected in human renal tubular cells and correlated with expression of angiotensin II in renal biopsies from 19 patients with IgA nephropathy. INNOVATION AND
CONCLUSION: This study demonstrated for the first time that AOPPs modified albumin functions as a strong trigger of intrarenal RAS via a CD36-mediated, redox-dependent pathway. Given the fact that accumulation of AOPPs is prevalent in diabetes and CKD, targeting AOPPs could be a strategy for the therapeutic intervention of CKD. Antioxid. Redox Signal. 18, 19-35.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22662869      PMCID: PMC3503474          DOI: 10.1089/ars.2012.4603

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  49 in total

1.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria.

Authors:  Osamu Takase; Takeshi Marumo; Naohiko Imai; Junichi Hirahashi; Atsushi Takayanagi; Keiichi Hishikawa; Matsuhiko Hayashi; Nobuyoshi Shimizu; Toshiro Fujita; Takao Saruta
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

3.  Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

Authors:  M G Seikaly; B S Arant; F D Seney
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Efficacy and safety of benazepril for advanced chronic renal insufficiency.

Authors:  Fan Fan Hou; Xun Zhang; Guo Hua Zhang; Di Xie; Ping Yan Chen; Wei Ru Zhang; Jian Ping Jiang; Min Liang; Guo Bao Wang; Zheng Rong Liu; Ren Wen Geng
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

5.  Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria.

Authors:  R Largo; D Gómez-Garre; K Soto; B Marrón; J Blanco; R M Gazapo; J J Plaza; J Egido
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

6.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.

Authors:  V Witko-Sarsat; M Friedlander; T Nguyen Khoa; C Capeillère-Blandin; A T Nguyen; S Canteloup; J M Dayer; P Jungers; T Drüeke; B Descamps-Latscha
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells.

Authors:  Junbo Ge; Qingzhe Jia; Chun Liang; Yukun Luo; Dong Huang; Aijun Sun; Keqiang Wang; Yunzeng Zou; Haozhu Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-11       Impact factor: 8.311

8.  Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats.

Authors:  L P Yao; X X Li; P Y Yu; J Xu; L D Asico; P A Jose
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

9.  Protein kinase C isozyme expression and down-modulation in growing, quiescent, and transformed renal proximal tubule epithelial cells.

Authors:  L Dong; J L Stevens; D Fabbro; S Jaken
Journal:  Cell Growth Differ       Date:  1994-08

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  38 in total

1.  Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction through the Bcl-2/Bax apoptotic pathway.

Authors:  Min Liang; Aiqing Li; Aiju Lou; Xifang Zhang; Youyuan Chen; Lei Yang; Yumin Li; Shenglin Yang; Fan Fan Hou
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

2.  Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury.

Authors:  Daisuke Kadowaki; Makoto Anraku; Moe Sakaya; Sumio Hirata; Toru Maruyama; Masaki Otagiri
Journal:  Clin Exp Nephrol       Date:  2015-04-23       Impact factor: 2.801

3.  A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression.

Authors:  Wei Cao; Aiqing Li; Liangliang Wang; Zhanmei Zhou; Zhengxiu Su; Wei Bin; Christopher S Wilcox; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 10.121

4.  In Vitro Oxidation of Collagen Promotes the Formation of Advanced Oxidation Protein Products and the Activation of Human Neutrophils.

Authors:  Guilherme Vargas Bochi; Vanessa Dorneles Torbitz; Luízi Prestes de Campos; Manuela Borges Sangoi; Natieli Flores Fernandes; Patrícia Gomes; Maria Beatriz Moretto; Fernanda Barbisan; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

5.  Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.

Authors:  Lili Zhou; Hongyan Mo; Jinhua Miao; Dong Zhou; Roderick J Tan; Fan Fan Hou; Youhua Liu
Journal:  Am J Pathol       Date:  2015-10-24       Impact factor: 4.307

6.  Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy.

Authors:  Jun Wang; Min Liang; Jie Xu; Wei Cao; Guo B Wang; Zhan M Zhou; Jian W Tian; Nan Jia; Zhenhai Zhang; Jing Nie; Youhua Liu; Fan F Hou
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

Review 7.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

8.  Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.

Authors:  Anthony J Valente; Tadashi Yoshida; Robert A Clark; Patrice Delafontaine; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Free Radic Biol Med       Date:  2013-02-20       Impact factor: 7.376

9.  Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells.

Authors:  Ebaa M Alzayadneh; Mark C Chappell
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-06-24       Impact factor: 1.636

10.  An alternative pathway through the Fenton reaction for the formation of advanced oxidation protein products, a new class of inflammatory mediators.

Authors:  Guilherme Vargas Bochi; Vanessa Dorneles Torbitz; Lara Peruzzolo Cargnin; José Antonio Mainardi de Carvalho; Patrícia Gomes; Rafael Noal Moresco
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.